INTRODUCTION
During the initial stages of a T cell-dependent antibody response, a subset of antigen-specific B cells proliferates in the extrafollicular regions of spleens and lymph nodes to become short-lived antibody-secreting plasmablasts and plasma cells (Fagraeus, 1948; Sze et al., 2000) . These cells are thought to survive for only several days before undergoing apoptosis (Jacob et al., 1991; Smith et al., 1994; Sze et al., 2000) . Other antigen-specific B cells initiate germinal center reactions where affinity maturation occurs (Berek et al., 1991) . Affinity-matured germinal center B cells survive to become either memory B cells or long-lived plasma cells (LLPCs) residing mostly in the bone marrow (Benner et al., 1981) .
LLPCs can live for years after infection or vaccination (Amanna et al., 2007; Manz et al., 1997; Slifka et al., 1998) . These LLPCs secrete several thousand antibody molecules per second irrespective of the presence of antigen (Ahuja et al., 2008; Cambridge et al., 2003; DiLillo et al., 2008; Hibi and Dosch, 1986; Manz et al., 1998) . The quantity, specificity, and duration of serum antibody production by LLPCs are the major correlates of protection for most clinically used vaccines (Amanna and Slifka, 2011) . Yet the lack of durability has been a problem in certain vaccines, as was observed in the recent RTS,S/AS01E malaria clinical trial (Olotu et al., 2013) . A number of intrinsic plasma cell survival molecules have been identified (O'Connor et al., 2004; Peperzak et al., 2013; Rozanski et al., 2011; Shapiro-Shelef et al., 2005; van Spriel et al., 2012) , but each of these are similarly expressed between LLPCs and short-lived plasma cells (SLPCs) (Shi et al., 2015) . Because the survival and metabolic pathways that specifically regulate LLPC survival remain largely unknown, optimization of the durability of vaccine-mediated immunity remains a major challenge.
As B cells differentiate into plasma cells, profound metabolic changes occur. Activated B cells increase cell surface expression of the glucose transporter Glut1 and undergo mechanistic target of rapamycin complex 2-dependent proliferation (CaroMaldonado et al., 2014; Doughty et al., 2006; Dufort et al., 2007; Lee et al., 2013; Woodland et al., 2008) . Glucose uptake is used to fuel glycolysis, electron transport chain activity, and synthesis of lipids for expansion of the endoplasmic reticulum (Dufort et al., 2014; Garcia-Manteiga et al., 2011) . X-box binding protein 1 drives expression of mitochondrial and endoplasmic reticulum biosynthesis and stress-related genes (Jang et al., 2015; Shaffer et al., 2004; van Anken et al., 2003) . By providing metabolic substrates, autophagy is also important for plasma cells (Pengo et al., 2013 ). Yet it is unclear whether specific metabolic pathways functionally differentiate LLPCs from SLPCs. In other cell types such as neurons and memory T cells, maximal respiratory capacity correlates with longevity (Choi et al., 2009; van der Windt et al., 2012) . Here, we established mitochondrial pyruvate import as a critical metabolic pathway that distinguished SLPCs from LLPCs and was essential for the durability of antibody-mediated immunity. Figure S1 .
RESULTS

LLPCs but Not SLPCs Can Engage Pyruvate-Dependent Respiration
We hypothesized that to maintain their remarkable rate of antibody production, LLPCs use unique metabolic pathways unavailable to their short-lived counterparts. We measured mitochondrial oxygen consumption rates in mouse B220 À CD138 high bone marrow cells, which are enriched for LLPCs (Chernova et al., 2014) , and B220 low CD138 high splenic cells isolated 7 days after immunization with 4-hydroxy-3-nitrophenyl-chicken gamma globulin (NP-CGG), which are enriched for SLPCs (Smith et al., 1994) ( Figure S1A ). Basal rates of oxygen consumption were similar between LLPCs and SLPCs ( Figure 1A ). Addition of oligomycin, an inhibitor of ATP synthase, led to a similar decline in oxygen consumption rates in LLPCs and SLPCs ( Figure 1A ). However, addition of the ionophore carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP) led to a much higher maximal oxygen consumption rate by LLPCs than by SLPCs ( Figure 1A ).
NP-binding SLPCs also showed low maximal respiration (Figure S1B) . Human bone marrow LLPCs also had more maximal respiratory capacity than did tonsillar SLPCs ( Figures 1B,  S1C) . Addition of the electron transport chain inhibitors rotenone and antimycin A led to a complete block of oxygen consumption ( Figures 1A and 1B) . These results indicated that LLPCs had greater maximal respiratory capacity than SLPCs. We next sought to identify metabolic pathways that support the elevated maximal respiratory capacity of LLPCs. Addition of UK5099, an inhibitor of mitochondrial pyruvate import, had no immediate effect on respiration but markedly attenuated maximal respiratory capacity after FCCP treatment in both mouse and human LLPCs, leaving them with a metabolic profile similar to that of SLPCs ( Figures 1C and 1D ). In contrast, addition of etomoxir, an inhibitor of long-chain fatty acid (LCFA) transport into the mitochondria, attenuated both basal and maximal respiration in mouse and human LLPCs ( Figures 1E and 1F ). Combined addition of UK5099 and etomoxir led to an additive inhibition of maximal respiration ( Figure S1D ). Etomoxir treatment of SLPCs also attenuated respiration, while UK5099 inhibited the small increase in respiratory capacity after FCCP treatment (Figure S1E) . Inhibition of amino acid catabolism had no immediate effect on respiration in LLPCs ( Figures S1F and S1G ). These data demonstrated that the relative ability to engage pyruvate-dependent respiration distinguished LLPCs from SLPCs.
Mitochondrial Pyruvate Import Is Essential for Maintenance of LLPCs In Vivo Pyruvate-dependent respiration was observed only after treatment with FCCP in vitro. Thus, it remained unclear whether this pathway is ever used by LLPCs. To address this point, we observed that in the absence of cytokines, LLPCs exhibited enhanced survival rates relative to SLPCs in vitro, but this advantage was eliminated upon treatment with UK5099 ( Figure 2A ). The molecular target of UK5099 is the mitochondrial pyruvate carrier composed of Mpc1 and Mpc2, each of which is essential for its function (Bricker et al., 2012; Herzig et al., 2012) . To assess the importance of plasma cell mitochondrial pyruvate in vivo, we used Mpc2 fl/fl mice (McCommis et al., 2015) , as constitutive deletion of Mpc2 is embryonically lethal (Vigueira et al., 2014 Figure 2C ). Two weeks after tamoxifen treatment, follicular B cell chimerism was unaffected by deletion of Mpc2 (Figures 2D and 2E, S2A) , despite efficient removal of the gene ( Figure S2B ). In contrast, Mpc2-deficient LLPC frequency was substantially diminished relative to control chimeras ( Figures 2D and 2E ). This was likely an underestimate of the requirement for mitochondrial pyruvate import, as residual LLPCs showed evidence of incomplete deletion of Mpc2 ( Figure S2B ). Nonetheless, we observed a reduction in maximal respiratory capacity in Mpc2-deficient bone marrow plasma cells ( Figure S2C ). Because SLPCs persist for only 1-3 days in vivo (Sze et al., 2000) , we were unable to quantify effects on the lifespans of these cells in this system. However, UK5099 did not markedly accelerate SLPC death in vitro (Figure 2A Figure 2F ). Chimeras were vaccinated against West Nile virus (WNV), antigenspecific LLPCs were allowed to form over the course of 6 weeks (Purtha et al., 2011) , and mice were treated with tamoxifen. No differences were observed in control WNV-specific serum Figure 2H ). These data demonstrated an intrinsic requirement for mitochondrial pyruvate metabolism to maintain LLPCs and antigen-specific antibodies in vivo. Given the requirement for Mpc2 in LLPCs, we considered the possibility that plasma cells use pyruvate as the major carbon source for respiration in vivo, in contrast to our in vitro results ( Figures 1C-1F ). We pretreated mice with UK5099 or etomoxir and intravenously injected a methyl ester of tetramethylrhodamine (TMRM), a dye that reports mitochondrial membrane potential (Scaduto and Grotyohann, 1999) . TMRM staining is reduced by a loss of respiratory substrates both in culture and in vivo (Hall et al., 2013; Vander Heiden et al., 2001) . Treatment with etomoxir consistently reduced the mean fluorescent intensity (MFI) of TMRM staining in bone marrow plasma cells, indicating that LCFAs serve as basal respiratory substrates (Figure 3A) . UK5099 caused a reduction in mitochondrial membrane potential in a subset of bone marrow cells, but had no reproducible effect on the MFI of TMRM staining of plasma cells ( Figure 3B ). To confirm these results genetically, we injected TMRM into Mpc2 fl/fl :ROSA26 CreER or control chimeras treated with tamoxifen. No differences in TMRM MFI were observed between donor and residual wild-type host bone marrow plasma cells ( Figure 3C ). These results indicated that LCFAs played a major role in basal LLPC respiration in vivo.
To reconcile the contribution of LCFAs to respiration with the requirement for mitochondrial pyruvate in LLPC maintenance in vivo, we hypothesized that these two types of substrates play non-redundant roles. To test this hypothesis, we transduced hematopoietic stem and progenitor cells from CD45.2 +
Mpc2
fl/fl :ROSA26 CreER mice with retroviruses and transplanted them competitively into irradiated CD45.1 + recipients ( Figure 3D ). Retroviral expression of Mpc2 specifically protected plasma cells from deletion of endogenous Mpc2 (Figures 3D, S3A). As expected (O'Connor et al., 2004; Peperzak et al., 2013) , anti-apoptotic protein Myeloid cell leukemia 1 (Mcl1) expression promoted overall plasma cell survival, but did not confer specific protection against Mpc2 deficiency ( Figure 3D ). Solute carrier 27a1 (Slc27a1), a plasma membrane LCFA transporter (Schaffer and Lodish, 1994) , is not endogenously expressed by LLPCs but retroviral expression promoted uptake of LCFAs ( Figures S3B and S3C ). Slc27a1 expression protected neutrophils from Mpc2 deficiency ( Figures S3D and S3E ), but failed to rescue plasma cells ( Figure 3D ). These data suggest that mitochondrial pyruvate and LCFAs play distinct roles in plasma cells in vivo.
LCFAs cannot be used for anaplerotic reactions to replace tricarboxylic acid cycle intermediates in mammals (Lehninger et al., 2013) . Thus, mitochondrial pyruvate might be essential for anaplerosis and cataplerosis in LLPCs. For example, proliferating cells are rescued from pyruvate-and respiration-deficiency by providing aspartate through the expression of the amino acid transporter solute carrier 1a3 (Slc1a3) (Birsoy et al., 2015; Kanai and Hediger, 1992) . Consistent with their requirement for glutamate and aspartate (Curi et al., 1997) , expression of Slc1a3 provided an advantage to neutrophils irrespective of Mpc2 expression ( Figure S3F ). However, Slc1a3 expression failed to protect plasma cells in vivo ( Figure 3D ). Expression of solute carrier 5a8 (Slc5a8), which promotes uptake of short-chain fatty acids such as anaplerotic propionate (Miyauchi et al., 2004) , also failed to rescue Mpc2 deficiency ( Figure 3D ). Finally, RNA-seq analysis of LLPCs revealed no transcriptional expression of pyruvate carboxylase (Pc), the major enzyme that catalyzes pyruvate-mediated anaplerosis ( Figure 3E ). In contrast, we observed high transcriptional expression of pyruvate dehydrogenase (Pdha1, Figure 3E ), which catalyzes formation of acetyl CoA. We observed low transcriptional expression of malic enzyme 2 (Me2) (Figure 3E ), but in vivo this enzyme preferentially decarboxylates malate to form pyruvate rather than the reverse reaction (Zelle et al., 2011) . Thus, we reasoned that pyruvate plays a non-redundant role with LCFAs not necessarily because of the unique anaplerotic reactions it can mediate, but potentially due to different metabolic cues that regulate its formation and oxidation. This could allow cells to respond more broadly to metabolic changes than would fatty acid metabolism alone.
Mitochondrion Function Similarly in SLPCs and LLPCs
We next wanted to understand how pyruvate formation and subsequent respiration were regulated in plasma cells. Increased mitochondrial mass could lead to an elevated maximal capacity to take up respiratory substrates. Through examination of electron microscopic images, we observed some morphological changes but no differences in the numbers of distinct mitochondrion between LLPCs and SLPCs ( Figure 4A ). Mitotracker Green and CM-H2TMRos dyes, which stain total and respiring mitochondrion, respectively, revealed no differences between LLPCs and SLPCs ( Figure 4B ). Next, LLPCs and SLPCs were permeabilized, thus allowing the direct delivery of substrates to the mitochondria without having to pass through cell surface transporters (Salabei et al., 2014) . Under these conditions, LLPCs and SLPCs oxidized pyruvate equivalently ( Figure 4C ). No oxygen consumption was observed when pyruvate was omitted ( Figure 4C ), and pyruvate had no effect on respiration unless cells were permeabilized (data not shown). Similar results were observed when permeabilized LLPCs and SLPCs were provided palmitoyl carnitine, a LCFA ( Figure 4D ). These data suggest that the increased maximal respiratory capacity in LLPCs was not driven by unique cell-intrinsic mitochondrial properties, but by respiratory substrates such as pyruvate which were less available to SLPCs.
LLPCs Constitutively Take Up Glucose Pyruvate can be provided by multiple different metabolic pathways, including glycolysis, amino acid catabolism, and direct uptake from extracellular sources (Halestrap, 2012) . We treated mouse LLPCs with sodium iodoacetate, an inhibitor of glyceraldehyde-3-phosphate dehydrogenase (GAPDH). GAPDH enzymatic activity is essential for pyruvate generation from glycolysis, but not other pathways. After iodoacetate treatment, maximal respiratory capacity in LLPCs was specifically attenuated (Figure 5A) . Reduction of glucose in the media also led to a loss of maximal respiratory capacity ( Figure 5B ). Thus glycolysis is likely the major source of mitochondrial pyruvate in LLPCs.
We reasoned that there were two possible mechanisms by which glucose specifically mediated the increase in respiration following FCCP treatment. First, glucose could be taken up only after FCCP treatment. Second, glucose could be constitutively taken up by LLPCs for other metabolic pathways, but then diverted to pyruvate production for respiration after FCCP. To distinguish between these alternatives, we measured in vitro uptake of a metabolizable fluorescent glucose analog, 2NBDG (Yoshioka et al., 1996) , with and without FCCP. Without FCCP, mouse LLPCs displayed more 2NBDG fluorescence than did SLPCs, indicating enhanced glucose import, potentially due to elevated expression of the glucose transporter GLUT1 (Figure S4A ). Both LLPCs and SLPCs displayed less 2NBDG fluorescence and expressed less cell surface GLUT1 after treatment with FCCP ( Figure S4A ). Treatment of cells with 2,4,-DNP, a different uncoupling agent, led to a similar degree of respiration as did treatment with FCCP ( Figure S4B ). These data demonstrated that LLPCs took up more glucose than SLPCs in vitro, and that this uptake was not enhanced by mitochondrial uncoupling.
To confirm these findings in vivo, we intravenously injected 2NBDG into mice that had been immunized with NP-CGG 7 days earlier. Mice were sacrificed 15 min after injection, and 2NBDG uptake in bone marrow and splenic plasma cells was measured. Approximately 80% of bone marrow plasma cells were 2NBDG high ( Figure 5C ). In contrast, only half of splenic plasma cells were 2NBDG high ( Figure 5C ). Because not all splenic plasma cells are necessarily short-lived (Sze et al., 2000) , we examined the 2NBDG high frequency in antigen-specific NP-binding splenic plasma cells. At Day 7 post-immunization, the majority of these cells are short-lived (Smith et al., 1994; Sze et al., 2000) . Within this mostly short-lived NP-specific compartment, only $20% of cells had taken up 2NBDG (Figure 5C ). At 6 weeks post-immunization, by which point most LLPCs have been formed and SLPCs diminish (Han et al., 1995; Weisel et al., 2016) , the majority of NP-specific bone marrow plasma cells were 2NBDG high ( Figure 5D ). Given that we were unable to identify NP-specific SLPCs within the splenic 2NBDG high compartment ( Figures 5C and 5D ), it seems likely that these cells represent long-lived splenic plasma cells that have been shown to exist by others (Sze et al., 2000) . Moreover, these data suggest that the differences we observed in glucose import were hallmark features of LLPCs versus SLPCs rather than traits imposed by distinct anatomical sites.
We next considered the possibility that plasma cell glucose uptake was a function of proliferation rather than longevity. In unimmunized mice, a subset of the splenic B220 + CD138 + compartment is proliferative, whereas the B220 À CD138 + population is quiescent ( Figure 5E , (Chernova et al., 2014; Kallies et al., 2004) ). Within both the proliferative B220 + and quiescent B220 À plasma cell compartments, approximately half the populations were 2NBDG high ( Figure 5F ). 2NBDG high splenic plasma cells displayed similar respiration as did bone marrow plasma cells under both high and physiological glucose and amino acid concentrations ( Figures 5G, S4C , Table S1 ). In contrast, 2NBDG low splenic plasma cells showed limited maximal respiratory capacity in high glucose media and were unable to increase respiration after FCCP treatment at physiological glucose levels ( Figures 5G and S4C) . 2NBDG low cells also exhibited a reduced basal respiration rate relative to their 2NBDG high counterparts under physiological glucose and amino acid conditions (Figure S4C ), but this difference was unaffected by UK5099 and therefore not mediated by pyruvate ( Figure S4D ). These data demonstrate that mouse LLPCs constitutively take up more glucose in vivo than do SLPCs irrespective of proliferative status.
LLPCs Use Glucose to Glycosylate Antibodies but Can Induce Glycolysis
Glucose is constitutively taken up by LLPCs, but minimally used for respiration in short time periods. Using intracellular staining (Baba, 1993) , we observed that glycogen levels were actually higher in SLPCs than in LLPCs ( Figure 6A ). These data suggest that glucose taken up by LLPCs is used for pathways other than glycogen synthesis.
To identify metabolic fates of glucose, we sought to perform tracing experiments. Given the paucity of mouse LLPCs, we first confirmed that human LLPCs also used glucose for maximal respiratory capacity ( Figure 6B ) and displayed higher 2NBDG fluorescence than did SLPCs after in vitro culture ( Figure 6C) . Human LLPCs were then cultured in 13 C glucose media. Mass spectrometry demonstrated that cells imported 13 C glucose and converted it to glucose-6-phosphate ( Figure 6D ). Yet we observed very little 13 C enrichment in pyruvate ( Figure 6D ). We observed comparably low 13 C enrichment in lactate, and no enrichment in aspartate or stearate ( Figure S5 ). UK5099 treatment diminished 13 C enrichment in citrate ( Figure 6D ), confirming that the small amount of pyruvate generated under these conditions could be transported into the mitochondria. These citrate isotopomers were labeled at 2, but not 3 atoms with 13 C, and thus were likely derived via pyruvate dehydrogenase and acetyl coA ( Figure 6D ). We observed substantial 13 C enrichment in mannose ( Figure 6D ), which is trimmed from glycoproteins by endoplasmic reticulum-resident mannosidases (Kornfeld and Kornfeld, 1985) .
13 C-enriched mannose suggests that glucose is used for glycosylation of secreted proteins, most of which are antibodies in LLPCs (Hibi and Dosch, 1986; Shi et al., 2015) . We next cultured human LLPCs with 14 C glucose to quantify the proportion that is used for antibody glycosylation. Antibodies were immunoprecipitated, treated with PNGase F to remove glycosylation, and 14 C counts were measured. Remarkably, $90% of cellular glucose was used for antibody glycosylation ( Figure 7A ). Glycosylation is essential for proper antibody secretion (Hickman et al., 1977) . Thus, we reasoned that 2NBDG low (legend continued on next page) SLPCs, which take up much less glucose than do LLPCs (Figures 5C-D) , would also secrete fewer antibodies. Indeed, 2NBDG low plasma cells secreted $5-fold fewer antibodies than did their 2NBDG high counterparts under physiological glucose and amino acid concentrations ( Figure 7B) .
The metabolic decision point between glycolysis and hexosamine biosynthesis for glycosylation occurs at fructose-6-phosphate, catalyzed by phosphofructokinase (PFK) and glutaminefructose-6-phosphate transaminase (GFPT1), respectively. We hypothesized that regulators that activate PFK activity, such as lowered ATP levels, would lead to the formation of pyruvate. Treatment of cells with oligomycin led to an increase in extracellular acidification rates (ECAR) through lactate excretion (Figure 7C) . Similarly, inhibiting the oxidation of alternate respiratory substrates such as long-chain fatty acids with etomoxir led to an increase in lactate ( Figure 7C ). ECAR was inhibited by iodoacetate ( Figure 7C ), demonstrating dependence on glycolysis and pyruvate production. Under physiological glucose conditions, LLPCs but not SLPCs were able to generate lactate after oligomycin or FCCP treatment ( Figure S4C ). We reasoned that stimuli which divert glucose to glycolysis and pyruvate for respiration would reduce antibody secretion, in part by limiting glycosylation. Overnight oligomycin treatment reduced LLPC viability (data not shown), but FCCP led to a marked decrease in antibody secretion ( Figure 7C ), without affecting survival (data not shown). Part of this effect might be indirect and caused by mitochondrial dysfunction. Yet taking together the experiments in Figure 7 , the data indicate that LLPCs predominantly use glucose to glycosylate antibodies, but also use glycolysis and pyruvate-dependent respiration under metabolic conditions that activate PFK. By virtue of their inability to take up as much glucose, SLPCs are less able to engage these pathways.
DISCUSSION
Durable antibody-mediated immunity to infections is mediated by LLPCs, and the majority of vaccines used clinically depend upon the production of neutralizing antibodies to confer protection (Amanna and Slifka, 2011) . Yet very little is known regarding features of the immunogen or host genetic factors that confer durable antibody responses. Thus, a better fundamental understanding of the mechanisms behind LLPC persistence is needed. Here, we have demonstrated that SLPCs and LLPCs are functionally distinguished by pyruvate-dependent mitochondrial respiratory capacity in vivo.
We observed that LLPCs imported more glucose constitutively in vivo than did SLPCs. Stimuli such as low ATP levels activated PFK, thus diverting glucose to glycolysis and pyruvate formation for respiration in LLPCs. Why this essential function could not be performed by LCFAs is unclear. One explanation is that the regulation of pyruvate formation and oxidation are not subject to the same controls as fatty acid oxidation. For example, malonyl coA is a major negative regulator of fatty acid oxidation (McGarry et al., 1977) , whereas ATP directly inhibits PFK (Garland et al., 1963) . By this logic, LLPCs have the ability to enact different metabolic switches in response to distinct changes in the environment. What are these changes? It is likely that pyruvate is made by LLPCs and used for respiration under normal conditions as an essential response to numerous perturbations that occur frequently. For example, serum glucose and free fatty acid concentrations vary substantially over the course of a day for many reasons including meals, circadian rhythms, etc. (Schlierf and Dorow, 1973) . Mitochondrial pyruvate import in LLPCs thus buffers against these changes to maintain energy homeostasis and durable humoral immunity.
Through the course of these studies, we discovered substantial heterogeneity within both bone marrow and splenic plasma cells in the ability to import a fluorescent glucose analog. Within the B220
À subsets of these populations, 2NBDG import correlated well with plasma cell longevity. Short-lived antigen specific plasma cells formed early after immunization were 2NBDG low , whereas long-lived antigen-specific plasma cells formed late in the response were mostly 2NBDG
high . Yet the functional significance of 2NBDG import in the B220 + plasma cell subset, which turns over rapidly (Chernova et al., 2014) , is unknown. The data imply that although glucose import and mitochondrial pyruvate import are necessary for long-term plasma cell survival, they might not be sufficient to prolong lifespan. Alternatively, the 2NBDG high subset of B220 + plasma cells might in fact be self-renewing and long-lived as a population (Tooze, 2013) .
Here we have shown that glucose import, pyruvate transport, and spare respiratory capacity are necessary for plasma cell longevity. An open question is which physiological signals promote these metabolic properties. The cell surface expression of Glut1 is higher in LLPCs than in SLPCs despite similar transcription. This implies the existence of LLPC-specific signals that promote Glut1 and/or other glucose transporter expression and activity post-transcriptionally. Knowledge of these signals could instruct rational vaccine design to enhance the durability of protection against infectious disease.
EXPERIMENTAL PROCEDURES
Detailed experimental procedures can be found in the Supplemental Information.
Mice
All procedures in this study were approved by the Institutional Animal Care and Use Committee at Washington University. C57Bl6/N mice were housed and bred in pathogen-free facilities. B6.Ly5.2 (CD45.1) mice used in chimera experiments were obtained from the National Cancer Institute, and C57BL/6J-IgH a mice were obtained from The Jackson Laboratory. Mpc2 fl/fl mice were generated as recently described (McCommis et al., 2015) . These mice were crossed to ROSA26-CreER mice obtained from The Jackson Laboratory.
Human Tissues
Tonsils were obtained from children undergoing elective tonsillectemy (St. Louis Children's Hospital). Bone marrow was obtained from total hip arthroplasty samples from patients undergoing elective surgery (Barnes Jewish Hospital). All samples were kept anonymous with no identifying information. All (legend continued on next page) procedures in this study were approved by the Human Research Protection Office at Washington University.
Flow Cytometry and Microscopy
For in vitro experiments, dyes were used as follows: Mitotracker Green FM (50 nM), Mitotracker Orange CMH2TMRos (100 nM), and 2NBDG (50 mg/ml). For in vivo 2NBDG stains, mice were injected retro-orbitally with 100 mg 2NBDG in PBS. For in vivo TMRM experiments, mice were treated with 2.5 mg etomoxir intravenously (i.v.) or 500 mg UK5099 intraperitoneally (i.p.) before being injected with 10 mg TMRM i.v. For glycogen stains, cells were fixed, permeabilized, and stained with 1 mg a-glycogen monoclonal antibody. For cell cycle analysis, cells were fixed, permeabilized, and incubated with 10 mg/ml DAPI. For transmission, EM cells were sorted and fixed in 2% paraformaldehyde /2.5% glutaraldehyde in 100mM cacodylate buffer pH 7.2. Sections were stained with uranyl acetate and lead citrate.
Extracellular Flux Assays
All extracellular flux assays were performed with Seahorse Bioscience XF96 Analyzers. Inhibitors were added at the following final concentrations: UK5099 (10 mM), etomoxir (20 mM) DON (50 mM), sodium iodoacetate (50 mM), oligomycin (1 mM), FCCP (1.5 mM), Rotenone (100nM), Antimycin A (1 mM), aminooxyacetic acid (500 mM). For permeabilization, cells were treated with 1nM perfringolysin O + 4 mM ADP + 0.5 mM malate in the presence or absence of 10 mM pyruvate or 40 mM palmitoyl carnitine (Salabei et al., 2014) .
RNA Sequencing
Libraries were made and single end 50 bp reads were acquired using an Illumina HiSeq 2500. Reads were mapped to the Ensembl_R72 reference human genome using Tophat. RNA-seq data can be downloaded with GEO accession GSE81443.
DNA Constructs and Retroviral Production
Constructs were cloned into the murine stem cell virus (MSCV)-IRES-GFP or MSCV-IRES-Thy1.1 vectors. Lenti-X 293T cells were cultured and transfected using 30 ml FuGene HD with 1.75 mg pMD2.G, 3.25 mg of pBS CMV-gag-pol, and 5 mg of retroviral vector. (B) Measurement of antibody secretion by mouse plasma cells. 10,000 polyclonal splenic and bone marrow plasma cell subsets from unimmunized mice as indicated were cultured for 16 hr in 5% O 2 and media containing 9 mM glucose and physiological concentrations of amino acids (see Table  S1 ). 
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